News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
T-VEC becomes first viral immunotherapy approved in Europe
A viral immunotherapy for cancer has become the first of its kind to be approved by the European Medicines Agency for use in adults with advanced melanoma.
Scientists discover how tumours hijack body’s wound healing process
Scientists have discovered how cells that usually help repair wounds can switch from friend to foe, escalating tumour growth and cancer spread.
ICR recognised as a top spot for pharmacology and drug discovery in the UK
The ICR wins a Pharmacology On The Map award from the British Pharmacological Society, to recognise our contribution to improving human health.
Local protein factories make cancer cells motile
Making key proteins at the driving edge of cancer cells is crucial for the spread of the disease around the body, new research concludes.
NICE makes decisions on use of three innovative cancer drugs on NHS: ICR statement
ICR CEO Professor Paul Workman comments on decisions by NICE today to recommend the drugs olaparib and enzalutamide for use on the NHS, but reject the ICR-discovered prostate cancer drug abiraterone.
ICR wins prestigious award for openness in animal research communication
The ICR has won a prestigious communications award that celebrates our success in communicating openly about animal research.
Imaging test detects aggressive and treatment-resistant cancers
ICR Scientists have developed a new imaging test that could enable doctors to identify more dangerous tumours before they spread around the body – and tailor treatment accordingly.
Highlights of the year, 2015
We look back at our researchers' scientific achievements to pick out ten of our most exciting discoveries from the past year.
The ICR opens its doors to schools across Sutton
The ICR gave local sixth formers across Sutton the chance to find out about our research at an open evening this week.
‘Master switch’ helps cancer cells survive stress
New survival mechanism could be a target for future cancer drugs
Carols by Candlelight
The stunning Wren Chapel of The Royal Hospital Chelsea was the setting for Carols from Chelsea – The Institute of Cancer Research’s flagship annual social and fundraising event.
New computational test predicts ovarian cancer survival
Scientists have developed a new automated way of predicting the survival chances from ovarian cancer from routine biopsy samples, by looking at the cells in the environment around tumours.
